Godrej Appliances is all set to commission 11,856 units of state of art vaccine refrigerators and deep freezers under the Universal Immunisation Programme by the Ministry of Health & Family Welfare in states across India over the next six months. 

These advanced medical equipments will be delivered at various state depots across the nation in 22 locations and will be commissioned at numerous government hospitals, district hospitals and health centres strengthening the cold chain for the massive immunisation programme run by the Indian Government. 

The brand has recently won the tender worth Rs 95 crore for 8767 units of ice-lined medical refrigerators and 3089 units of horizontal deep freezers through the bidding process.

Powered by Sure Chill Technology, Godrej medical refrigerators help maintain the optimum temperature range of 2-8 °C - a necessity for vaccine preservation and blood storage. This refrigerator maintains its temperature even in case of power outages for as long as 8-12 days in ambient temperatures of 43˚C. In regions without electric supply, the equipment can be teamed with solar power to deliver the same results. This also includes the Lite Series apt for peri-urban and urban areas wherein power outage is not a major issue and hence it comes with an adequate holdover of three days.  

On the other hand, Godrej medical freezers with D-cool Technology use D-shaped Copper Refrigerating Tube for more surface contact and large heat exchange area for delivering high refrigeration efficiency. It provides precision cooling at -20 °C. 

Speaking on the announcement, Kamal Nandi – Business Head and Executive Vice President – Godrej Appliances said, “We are proud to be a part of one of the largest immunisation programmes by the Ministry of Health & Family Welfare. Immunisation has long been the most effective way to fight and eradicate diseases”

Jaishankar Natarajan, Associate Vice President and Head - New Business Development, Godrej Appliances further added, “Vaccines exposed to either more than 8°C or less than 2°C lose potency and this results in significant losses both in human terms – the end-user does not get proper immunization and economic –government has to discard costly vaccines at zero salvage value.”